Patients with gestational diabetes show different disease progressions and therefore require personalized treatment measures. An international research team led by MedUni Vienna has now identified three subgroups of the disease with different treatment needs.
Lilly doubles down on radiopharma
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Please take